Role of Flow Cytometry in the Diagnosis of Inborn Errors of Immunity

Abstract

Inborn errors of immunity (IEI) are a group of inherited heterogeneous disorders affecting the immune system characterized by increased susceptibility to infections, immune dysregulation, and lymphoproliferation. Flow cytometry (FCM) is a rapid and reliable technique for evaluation and enumeration of immune cells. It also helps in understanding the functional and signaling pathways of the immune system. Lymphocyte subset analysis is a simple and effective screening tool in suspected combined and humoral immunodeficiency patients. Qualitative phagocytic defects such as chronic granulomatous disease and leucocyte adhesion defect are easily diagnosed by FCM. Study of intracellular proteins (e.g., BTK, WASP, DOCK8), cytokine production, and signaling molecules (e.g., STAT3) by FCM is very useful but also quite challenging to establish. T and B lymphocyte interaction for normal class switching of B cells can be assessed and can help in diagnosis of combined variable immunodeficiency and hyperimmunoglobulin M syndrome. FCM is also used in posttransplant monitoring of IEI patients and also in prenatal diagnosis in suspected cases. It is also useful in validation of variants of uncertain significance obtained in exome sequencing. FCM results should always be interpreted with clinical history and, if needed, should be confirmed with molecular genetic studies before establishing the final diagnosis. Ensuring good sample quality and running parallel controls with patient samples will avoid the preanalytical and analytical errors. This review describes the applications of FCM in the diagnosis of various IEI.

Keywords

inborn errors of immunity - flow cytometry - primary immunodeficiency - phagocytic defects - immune dysregulation - antibody deficiency

Publication History

Received: 20 July 2021

Accepted: 27 November 2021

Article published online:
03 January 2022

• References

• 1 Locke BA, Dasu T, Verbsky JW. Laboratory diagnosis of primary immunodeficiencies. Clin Rev Allergy Immunol 2014; 46 (02) 154-168
• 2 Madkaikar MR, Shabrish S, Kulkarni M. et al. Application of flow cytometry in primary immunodeficiencies: experience from India. Front Immunol 2019; 10: 1248
• 3 Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A. Flow cytometry: basic principles and applications. Crit Rev Biotechnol 2017; 37 (02) 163-176
• 4 Suni MA, Maino VC. Flow cytometric analysis of cell signaling proteins. Methods Mol Biol 2011; 717: 155-169
• 5 van Gent R, van Tilburg CM, Nibbelke EE. et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol 2009; 133 (01) 95-107
• 6 Fleisher TA, Madkaikar M, Rosenzweig SD. Application of flow cytometry in the evaluation of primary immunodeficiencies. Indian J Pediatr 2016; 83 (05) 444-449
• 7 O'Gorman MR. Clinically relevant functional flow cytometry assays. Clin Lab Med 2001; 21 (04) 779-794
• 8 Hanna S, Etzioni A. MHC class I and II deficiencies. J Allergy Clin Immunol 2014; 134 (02) 269-275
• 9 Rawat A, Arora K, Shandilya J. et al. Flow cytometry for diagnosis of primary immune deficiencies-a tertiary center experience from North India. Front Immunol 2019; 10: 2111
• 10 Middendorp S, Dingjan GM, Maas A, Dahlenborg K, Hendriks RW. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity. J Immunol 2003; 171 (11) 5988-5996
• 11 Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I. Advances in human B cell phenotypic profiling. Front Immunol 2012; 3: 302
• 12 O'Gorman MR, Zaas D, Paniagua M, Corrochano V, Scholl PR, Pachman LM. Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers. Clin Immunol Immunopathol 1997; 85 (02) 172-181
• 13 Yu JE, Azar AE, Chong HJ, Jongco III AM, Prince BT. Considerations in the diagnosis of chronic granulomatous disease. J Pediatric Infect Dis Soc 2018; 7 (Suppl. 01) S6-S11
• 14 Mauch L, Lun A, O'Gorman MR. et al. Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clin Chem 2007; 53 (05) 890-896
• 15 Deshpande P, Kathirvel K, Alex AA. et al. Leukocyte adhesion deficiency-I: clinical and molecular characterization in an Indian population. Indian J Pediatr 2016; 83 (08) 799-804
• 16 Abraham RS, Aubert G. Flow cytometry, a versatile tool for diagnosis and monitoring of primary immunodeficiencies. Clin Vaccine Immunol 2016; 23 (04) 254-271
• 17 Salzer U, Sack U, Fuchs I. Flow cytometry in the diagnosis and follow up of human primary immunodeficiencies. EJIFCC 2019; 30 (04) 407-422
• 18 Knight V. The utility of flow cytometry for the diagnosis of primary immunodeficiencies. Int J Lab Hematol 2019; 41 (Suppl. 01) 63-72
• 19 Saikia B, Rawat A, Minz RW. et al. Clinical Profile of hyper-IgE syndrome in India. Front Immunol 2021; 12: 626593
• 20 Alcántara-Montiel JC, Staines-Boone T, López-Herrera G. et al. Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohort. Clin Genet 2016; 89 (02) 217-221
• 21 Mishra A, Gupta M, Dalvi A, Ghosh K, Madkaikar M. Rapid flow cytometric prenatal diagnosis of primary immunodeficiency (PID) disorders. J Clin Immunol 2014; 34 (03) 316-322
• 22 Kelly BT, Tam JS, Verbsky JW, Routes JM. Screening for severe combined immunodeficiency in neonates. Clin Epidemiol 2013; 5: 363-369